Balstilimab (Anti-PDCD1 / PD-1 / CD279)
Balstilimab (Anti-PDCD1 / PD-1 / CD279) is a monoclonal antibody targeting the programmed cell death 1 (PD-1, PCD-1; PDCD1). It exhibits potential treatment of cervical cancer. MW :137.3 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A3027 |
Sku # | A3027-1mg*5 |
Pricing | 1mg*5, $1690.00 |